Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc.

About

16.80USD-0.16 -0.94%
Closed • Updated at 22:04 GMT+00:00
Market Cap$1.77B
Volume1.96M
Beta0.81
RSI32.70
Gross Margin60.59%
Health TechnologyPharmaceuticals: Major

Sarepta Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 13 2026
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 6 2026
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
Apr 22 2026
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
Mar 25 2026
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Mar 24 2026
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

Community Chat

Ask AI

Try asking
6ix6ixAIEvents